Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in Humans

Clinical trial NCT03443830 · COMPLETED

Trial details

NCT number: NCT03443830
Sponsor: Tychan Pte Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Treatment of Acute Zika Virus Infection

Start date: 2018-02-08
Primary completion: 2018-09-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.